Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/17/2025

Management of Erectile Dysfunction in Older Adults

Initial Assessment and Diagnosis

  • The American Urological Association recommends checking total morning testosterone level, as hypogonadism (testosterone <300 ng/dL) may be present and contribute to ED, especially in men over 65 years 3
  • Evaluate for cardiovascular risk factors (diabetes, hypertension, hyperlipidemia) as ED is often associated with cardiovascular disease and may be an early marker 4
  • Assess for psychological factors that may contribute to ED, including depression, anxiety, and relationship issues 2

First-Line Management: Lifestyle Modifications

  • Implement weight loss if overweight/obese, as recommended by the National Comprehensive Cancer Network 3
  • Increase physical activity, as aerobic exercise programs combined with PDE5 inhibitors are more effective than PDE5 inhibitors alone 3
  • Limit alcohol consumption, as recommended by the National Comprehensive Cancer Network 3
  • Optimize management of comorbid conditions (diabetes, hypertension, hyperlipidemia) 2

Second-Line Management: Pharmacological Therapy

  • The American College of Cardiology recommends starting with sildenafil, tadalafil, vardenafil, or avanafil as first-line pharmacological treatment for ED 1, 2
  • Begin with conservative dosing and titrate as needed for efficacy, as recommended by the National Comprehensive Cancer Network 3
  • Consider daily low-dose PDE5 inhibitor therapy as an alternative to on-demand dosing 3
  • Testosterone replacement therapy may improve ED symptoms if morning testosterone is <300 ng/dL, as recommended by the National Comprehensive Cancer Network 3, 2

Third-Line Management: Invasive Therapies

  • Consider alprostadil injections for patients who fail to respond to oral medications, as recommended by the American Urological Association 1
  • Vacuum constriction devices are a non-invasive mechanical option for ED, particularly useful in patients with contraindications to pharmacotherapy 1, 2
  • Penile prosthesis implantation is a surgical option for patients with refractory ED, with high satisfaction rates 1, 2

Additional Therapeutic Considerations

  • Consider psychosexual therapy or couples counseling as adjunctive treatment, especially if psychological factors are present, as recommended by the National Comprehensive Cancer Network 3, 2
  • Pelvic floor muscle training may improve sexual function, as recommended by the National Comprehensive Cancer Network 3
  • A multidisciplinary approach involving urology, endocrinology, and cardiology may be beneficial for patients with multiple comorbidities 2

Important Caveats

  • Assess cardiovascular risk before initiating treatment, as ED may precede coronary artery disease symptoms by approximately 3 years 4
  • Ensure the patient's cardiac condition is stable enough for sexual activity before prescribing ED treatments 4

REFERENCES

1

survivorship, version 2.2017, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2017

2

High Cholesterol and Erectile Dysfunction Connection [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

3

Erectile Dysfunction Management [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025